2Barehielli A, Amorosi A, Balzi D, et al. Long-term pronosis of gastric cancer in a European country:a population-based study in Florence(Italy).10-year survival of cases diagnosed in 1985-1987[J]. Eur J Cancer, 2001,37(13):1674-1680.
3Adachi Y, Suematsu T, Shiraishi N, et al. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer[J]. Br J Surg, 1998,85(9):1281-1284.
5Louvet C, Andre T, Tigaud JM, et al. Phase Ⅱ study of oxaliplatin, fluorouracil, and folinc acid in locally advanced or metastatic gastric cancer patients[J]. J Clin Oncol, 2002, 20(23):4543-4548.
6Matsui M, Kojima O, Kawakami S, et al. The prognosis of patients with gastric cancer possessing sex hormone receptors[J]. Surg Today, 1992,22 (5):421-425.
二级参考文献10
1Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176.
2Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616.
3Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687.
4Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301.
5Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002.
6Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166.
3Lee A,Fan L T.Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting[J].Cohrane Database Syst Rav,2009,15(2):3281.
